{{Rsnum
|rsid=1078806
|Gene=FGFR2
|Chromosome=10
|position=123338975
|Orientation=minus
|GMAF=0.3343
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 26.5 | 38.9 | 34.5
| HCB | 7.3 | 38.0 | 54.7
| JPT | 12.4 | 32.7 | 54.9
| YRI | 6.1 | 29.9 | 63.9
| ASW | 7.0 | 47.4 | 45.6
| CHB | 7.3 | 38.0 | 54.7
| CHD | 7.3 | 37.6 | 55.0
| GIH | 11.9 | 48.5 | 39.6
| LWK | 3.6 | 24.5 | 71.8
| MEX | 17.2 | 50.0 | 32.8
| MKK | 3.2 | 22.4 | 74.4
| TSI | 25.5 | 48.0 | 26.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=21382839
|Title=Relation of FGFR2 Genetic Polymorphisms to the Association Between Oral Contraceptive Use and the Risk of Breast Cancer in Chinese Women
|OA=1
}}

{{PMID Auto
|PMID=18326623
|Title=Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.
|OA=1
}}

{{PMID Auto
|PMID=19738052
|Title=A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23354978
  |Trait=Breast cancer
  |Title=Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.
  |RiskAllele=C
  |Pval=2E-6
  |OR=1.43
  |ORtxt=[NR]
  }}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}